MARKET

NVS

NVS

Novartis
NYSE
145.46
+1.89
+1.32%
After Hours: 145.50 +0.04 +0.03% 19:49 09/25 EDT
OPEN
144.57
PREV CLOSE
143.57
HIGH
145.51
LOW
144.00
VOLUME
1.17M
TURNOVER
--
52 WEEK HIGH
165.46
52 WEEK LOW
118.00
MARKET CAP
276.48B
P/E (TTM)
21.97
1D
5D
1M
3M
1Y
5Y
1D
Catalyst Watch: Jobs report, Trump AI talks, and ticking fee time for Paramount
Seeking Alpha · 2d ago
Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
TipRanks · 2d ago
FDA commissioner nominee Overton rebuffs questions about Trump medical claims
Seeking Alpha · 3d ago
Buy Rating Reiterated on Novartis as Diversified Pipeline Supports Medium-Term Growth; CHF 150 Price Target Unchanged
TipRanks · 3d ago
A Federal Judge In Manhattan Ruled For Novartis On Wednesday Against Allegations That It Misused One Of Its Patents To Maintain Its Exclusivity On Its Blockbuster Heart-Failure Drug Entresto
Benzinga · 4d ago
Ionis Delivers Positive Late-Stage Results for Two Partnered Drugs
NASDAQ · 4d ago
HSBC Remains a Buy on Novartis AG (NOVN)
TipRanks · 5d ago
Celldex Prepares For 2027 FDA Submission for Chronic Skin Disease
Benzinga · 5d ago
More
About NVS
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Webull offers Novartis AG (ADR) stock information, including NYSE: NVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVS stock methods without spending real money on the virtual paper trading platform.